EVE — Eve Health Income Statement
0.000.00%
Last trade - 00:00
- AU$5.27m
- AU$5.50m
- AU$2.33m
- 45
- 32
- 48
- 39
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.6 | 2.31 | 2.8 | 2.01 | 2.33 |
Cost of Revenue | |||||
Gross Profit | -0.037 | 0.874 | 1.31 | 0.745 | 0.828 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.37 | 4.93 | 6.28 | 7.03 | 4.77 |
Operating Profit | -1.78 | -2.62 | -3.48 | -5.02 | -2.43 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.64 | -3 | -3.63 | -5.12 | -2.35 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.64 | -2.4 | -3.63 | -5.12 | -2.35 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.64 | -2.4 | -3.63 | -5.37 | -4.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.64 | -2.4 | -3.63 | -5.37 | -4.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.001 | -0.001 | -0.001 | -0 |